期刊文献+

老年早期糖尿病肾脏疾病患者左心室舒张功能不全的相关因素分析 被引量:1

Related factors of left ventricular diastolic dysfunction in elderly patients with early diabetic kidney disease
下载PDF
导出
摘要 目的:探讨影响老年早期糖尿病肾脏疾病(diabetic kidney disease,DKD)患者左心室舒张功能的相关因素。方法选取老年早期 DKD 患者89例,组织多普勒测定心脏舒张功能,分为左心室舒张功能不全组及左心室舒张功能正常组。分析2组患者临床特点以及血 pH 值、血红蛋白(he-moglobin,Hb)、糖化血红蛋白浓度、尿素氮、血肌酐、尿酸、血钙、血磷、N 末端 B 型利钠肽原(N termi-nal B type natriuretic peptide,NT-proBNP)、甲状旁腺素等的差异。引入多因素非条件 Logistic 回归分析,探讨左心室舒张功能不全的独立危险因素,并对相关因素进行 ROC 曲线分析。结果89例老年早期 DKD 患者中,66例存在左心室舒张功能不全,发生率为74.2%。左心室舒张功能不全组与左心室舒张功能正常组,年龄为[(72.6±5.0)岁比(68.9±5.5)岁,P 〈0.01];糖尿病病程为[(10.9±3.2)年比(7.5±2.5)年,P 〈0.01];估算肾小球滤过率(estimated glomerular filtration rate,eGFR)值为[(55.8±17.2)ml·min^-1·(1.73 m^2)^-1比(66.1±15.9)ml·min^-1·(1.73 m^2)^-1,P 〈0.05];Hb 为[(111.2±15.1)g/L 比(124.3±18.4)g/L,P 〈0.01];血钙为[(8.75±0.84)mmol/L 比(9.68±0.78)mmol/L,P 〈0.01];血磷为[(4.12±0.41)mmol/L 比(3.80±0.49)mmol/L,P 〈0.01];NT-proBNP 为[(269.5±46.8)ng/L 比(222.3±45.3)ng/L,P 〈0.01]。多因素非条件 Logistic 回归分析显示,年龄和低钙血症是左心室舒张功能不全的独立危险因素(年龄:OR=2.405,95% CI=1.789~3.460,P 〈0.05;低钙血症:OR=2.961,95% CI=2.321~3.951,P 〈0.01)。ROC 曲线分析显示低钙血症和 NT-proBNP 对左心室舒张功能不全有诊断价值。结论老年早期 DKD 患者普遍存在左心室舒张功能不全,低钙血症程度与左心室舒张功能不全之间有相关关系,并且是左心室舒张功能不全的独立预测因素。 Objective To investigate and analyze the related factors of left ventricular diastolic function in elderly patients with early diabetic kidney disease (DKD).Methods The study group con-sisted of 89 elderly patients with early DKD.Standard echocardiography was performed in all patients with tissue Doppler echocardiography for the evaluation of early (E)and late (A)transmitral veloci-ties.Patients were divided into two groups according to the results of E/A:group with LV diastolic dysfunction (E/A〈1)[DF (+)]and group with normal LV diastolic function [DF (-)]when E/A≥1 .Clinical manifestations and the laboratory parameters [serum creatinine concentration,and the levels of urea,P,Ca,parathormone,platelet count,hemoglobin level,and N-terminal pro-B-type na-triuretic peptide(NT-proBNP)levels]were compared between two groups.Different parameters were analyzed by multivariate Logistic regression.Diagnostic value of related factors in left ventricular dias-tolic dysfunction was analyzed by ROC curve.Results Sixty-six(74.2%)patients had left ventricular diastolic dysfunction.Age,duration of diabetes,estimated glomerular filtration rate,serum calcium and NT-proBNP were statistically different between two groups[group with LV diastolic dysfunction VS.group with normal LV diastolic function,age:(72.6 ±5.0)years VS.(68.9 ± 5.5 )years,P 〈0.01 ;duration of diabetes:(10.9 ± 3.2)years VS.(7.5 ± 2.5 )years,P 〈 0.01 ;eGFR:(55.8 ± 1 7.2)ml·min^-1·(1 .73 m^2 )^-1 VS.(66.1 ± 1 5.9)ml·min^-1·(1 .73 m^2 )^-1 ,P 〈0.05;Hb:(1 1 1 .2 ± 1 5.1)g/L VS.(124.3±1 8.4)g/L,P 〈0.01 ;serum Ca:(8.75 ±0.84)mmol/L VS.(9.68 ±0.78) mmol/L,P 〈0.01 ;serum P:(4.12 ± 0.41 )mmol/L VS.(3.80 ± 0.49)mmol/L,P 〈 0.01 ;NT-proBNP:(269.5±46.8)ng/L VS.(222.3 ±45.3)ng/L,P 〈0.01 ].Multivariate Logistic regression analysis showed that age and hypocalcemia were independent risk factors for left ventricular diastolic dysfunction(age:OR=2.405,95% CI= 1 .789~3.460,P 〈0.05;hypocalcemia:OR=2.961 ,95%CI=2.321 ~3.95 1 ,P 〈0.01).ROC curve analysis showed hypocalcemia and NT-proBNP had diag-nostic value in left ventricular diastolic dysfunction.Conclusions Hypocalcemia extent in elderly pa-tients with early DKD was related to left ventricular diastolic dysfunction,and is independent predictor of left ventricular diastolic dysfunction.
出处 《临床肾脏病杂志》 2015年第9期535-539,共5页 Journal Of Clinical Nephrology
基金 常州市科技计划项目(NO.CS2008210) 南京医科大学科技发展基金面上项目(NO.08NMUM037) 南京医科大学科技发展基金重大项目(NO.09NJMUZ25)
关键词 糖尿病肾脏疾病 低钙血症 左心室 Diabetic kidney disease Hypocalcemia Ventriculus sinister
  • 相关文献

参考文献21

  • 1王晓慧,张新,何泳,李明梅,杨国胜,王智斌.早期糖尿病肾病患者合并动脉粥样硬化危险因素分析[J].临床肾脏病杂志,2015,15(3):147-150. 被引量:2
  • 2李社冉,牛建英,顾勇.糖尿病肾脏疾病流行病学研究概况[J].临床肾脏病杂志,2014,0(10):635-638. 被引量:12
  • 3Randhawa FA, Hussnain MT, Nazir S, et al. Frequency of diastolic dysfunction in asymptomatic, normotensive type-2 di- abetic patients[J]. J Ayub Med Coll Abbottabad, 2014, 26 (1):35-37.
  • 4Tateishi Y, Tsujino A, Hamabe J, et al. Cardiac diastolic dysfunction predicts in-hospital mortality in acute ischemic stroke with atrial fibrillation[J]. J Neurol Sci, 2014, 345 (1- 2) : 83-86.
  • 5Farshid A, Pathak R, Shadbolt B, et al. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease[J]. BMC Nephrol, 2013, 14: 280.
  • 6Ruz-del-rbol L, Achcar L, Serradilla R, et al. Diastolic dys- function is a predictor of poor outcomes in patients with cirrho- sis, portal hypertension, and a normal creatinine[J]. Hepatol- ogy, 2013, 58(5): 1732-1741.
  • 7Cai L. Diabetic cardiomyopathy and its prevention by metallo-thionein:experimental evidence, possible mechanisms and clin- ical implications[J]. Curr Med Chem, 2007, 14(20): 2193- 2203.
  • 8Kubesova HM, Weber P, Meluzinova H, et al. Benefits and pitfalls of cardiovascular medication in seniors[J]. Wien Klin Wochenschr, 2013, 125(15-16) : 425-436.
  • 9Murdoch CE, Chaubey S, Zeng L, et al. Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosisand diastolic dys- function through proinflammatory effects and endothelial-mes- enchymal transition[J]. J Am Coll Cardiol, 2014, 63 (24) : 2734-2741.
  • 10Valle R, Bagolin E, Canali C, et al. The BNP assay dos not identify mild left ventricular diastolic dysfunction in asympto- matic diabetic patients[J]. Eur J Echocardiography, 2006, 7 (1) : 40-44.

二级参考文献70

  • 1中华医学会心血管病学分会.中华心血管病杂志编辑委员会,急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,:38-208,195.
  • 2Seino Y, Ogawa A, Yamashita T, et al. Application of NT-pro?BNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. EurJ Heart Fail, 2004, 6: 295-300.
  • 3Moro C, Berlan M. Cardiovascular and metaholic effects of natriuretic peptides. Fundam Clin Pharmacol, 2006, 20: 41-49.
  • 4Troughton RW, Richards M. B-type natriuretic peptides: appli?cations for heart failure management in 2005. Intern MedJ, 2005, 35: 377-379.
  • 5Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emer?gency Department (PRIDE) echocardiographic substudy. Eur HeartJ. 2006, 27: 839-845.
  • 6Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart, 2006, 92: 843-849.
  • 7郭华涛,徐丽华,张远卓,等.血浆NT—proBNP在老年舒张性心力衰竭患者早期诊断中的价值.中国老年医学杂志,2010,30:1181.1183.
  • 8Silva CE, Ferreira LD, Peixoto LB, et al. Study of the myocar?dial contraction and relaxation velocities through Doppler tissue imaging echocardiography: a new alternative in the assessment of the segmental ventricular function. Arq Bras Cardiol, 2002, 78: 200-211.
  • 9Cohen GI, PietrolungoJF, ThomasJD, et al. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography.J Am Coli Cardiol , 1996, 27: 1753-1760.
  • 10Yu CM, SandersonJE, Marwick TH, et al. Tissue Doppler imaging a new prognosticator for cardiovascular diseases.J Am Coli Cardiol, 2007, 49: 1903-1914.

共引文献12

同被引文献14

  • 1史晓敏,徐国宾,夏铁安.肾功能与N末端B型钠尿肽原的关系及其在慢性心力衰竭诊断中的应用[J].中华检验医学杂志,2006,29(12):1089-1092. 被引量:13
  • 2朱红俊,龚少愚,邹逊,魏慧渊,陆曙.心力衰竭病因对血浆BNP水平的影响[J].临床荟萃,2007,22(1):27-28. 被引量:25
  • 3周文彦,倪兆慧,顾乐怡,方炜,王琴,牟姗,曹励欧,俞赞喆,钱家麒.慢性肾脏病非透析患者脑钠素与肾功能及左室肥厚的关系[J].中华医学杂志,2007,87(46):3284-3287. 被引量:4
  • 4Stack, ACT, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure a- mong incident US dialysis patients[J]. Am J Kidney Dis, 2001, 38(5) : 992 t000.
  • 5Jarai R, Kaun C, Weiss TW, et al. Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin lalpha, tumour necrosis factor a] pha and transforming growth factor-beta[J]. J Cell Mol Med, 2009, 13(11 12): 4415 4421.
  • 6European Society of Cardiology. Guidelines for he diagnosis and treatment of chronic heart failure[J]. Eur J Heart, 2001 , 22(17): 1527 1560.
  • 7Ng, LL, Loke I, Davies JE, et al. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography [J]. Eur J Heart Fail, 2003, 5(6) : 775 782.
  • 8Cataliotti A, Malatino LS, Jougasaki M, et al. Circulating na triuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biornarker for ventricular remodeling[J]. Mayo Clin Proc, 2001, 76 ( 11 ) : 1111-1119.
  • 9Vickery, S, Price CP, John R I, et al. B-type natriuretic pep tide(BNP) and aminc-terminal proBNP in patienls with CKD.- relationship to renal function and left ventricular hypertrophy [J]. Am J Kidney Dis, 2005, 46(4) : 610 620.
  • 10Luehner A, Hengstenberg C, Lowel H, et al. Effect of com pensated renal dysfunction on approved heart failure markers direct comparison of brain natriuretic peptide(BNP) and N-ter minal prcBNP[J]. Hypertension, 2005, 46 ( 1 ) : 118 123.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部